Header Image
ADHD in adults

Sitemap

ADHD in adults

Author: Ulrich Brennecke
Review: Dipl.-Psych. Waldemar Zdero

ADHD does not, as was assumed until the end of the last millennium,1 automatically end with adulthood.

ADHD persists into adulthood in around two thirds of people with ADHD. Many show changes in symptoms, while others may experience complete remission or remission with fluctuating phases. Up to 90% of persons with ADHD still have residual symptoms or significant limitations in young adulthood compared to people without ADHD. Various reasons for the persistence of ADHD into adulthood are discussed, such as a low socio-economic background, high stress levels in childhood or late traumas. One theory assumes that ADHD already exists in childhood, but is masked by coping mechanisms and becomes visible in adulthood. Late-onset ADHD, i.e. a first appearance (or at least becoming recognizable) in adulthood, is possible and can occur in up to 10% of ADHD cases, especially in women.
The symptoms of ADHD change in adults compared to children, with hyperactivity decreasing and inner restlessness, inattention and organizational problems coming to the fore.

Treatment of ADHD in adults often requires lower doses of stimulants compared to children.

1. Prevalence of the persistence of ADHD into adulthood

5 % of all children have ADHD (a further 5 % are suspected of having ADHD). In the USA, around 4.4 % of all adults are affected by ADHD.23 Further studies can be found at Krause.4

65 %5 to 90 %6 to 100 %7 of people with ADHD show at least residual symptoms or significant limitations in terms of educational and professional success into young adulthood compared to non-affected people.
63.8% showed fluctuating phases of remission and recurrence during childhood and young adulthood 89
In adulthood, people with ADHD - with altered symptoms - persist throughout their lives with - depending on the study -

  • 22 %10
  • 35 %89
  • 50 %11
  • around 66 % (which should be the most resilient)1213 11
    Complete remission in adulthood is found in around 30% of children with ADHD.611

One study observed in adults whose previous ADHD remitted that only the symptom groups

  • Executive problems
  • Behavioral problems

were remitted, while

  • Hyperactivity/restlessness behavior
  • Planning/organizational deficits

persisted.14

A large international study even found a higher prevalence of ADHD in adults (2.8%) than in children (2.2%).15 This could be consistent with the fact that the heritability of adult ADHD is possibly lower than that of child ADHD, i.e. that the proportion of environmental influences on the development of ADHD could be higher in adults than in children.16

2. Possible reasons for the persistence of ADHD into adulthood

It is not possible to predict in which persons with ADHD ADHD will disappear in adulthood. Whether persons with ADHD lose their ADHD by the age of 27 is independent of

  • The severity of the Disorder17
  • The age at first onset of ADHD17
  • The IQ of childhood17
  • Behavioral problems in childhood17
  • The severity of ADHD-HI, ODD or CD17
  • The duration of stimulant treatment after adolescence17

There are various theories as to why childhood ADHD disappears in some adults and persists in others.

  • Children with ADHD from a low socio-economic background benefited more from special school support than children from higher socio-economic backgrounds.18 In our view, this indicates that families with a low socio-economic status are less able to compensate for their children’s deficits. This is likely to apply to all mental health problems.
  • A study of stress exposure in children with ADHD found that severe stress exposure in childhood and adolescence was associated with severe ADHD-HI or ADHD-I progression into adulthood, while children with low stress exposure often showed remitting ADHD (all subtypes).19 A large cohort study in Sweden confirms this20
  • Another study found an up to 11.8-fold increase in trauma in late-onset ADHD. Neurophysiologically, late-onset ADHD did not differ from ADHD in people with ADHD who had had it since childhood. However, the effects were significantly stronger. At the same time, 1/3 of the late-onset ADHD sufferers were no longer diagnosed with ADHD after one year.21 The latter could also be an indication of a high rate of misdiagnosis.
    • Puberty is associated with a strongly altered dopaminergic innervation in the PFC. The PFC is particularly vulnerable to dopaminergic stimulation during this time. This explains the fluctuating behavior of adolescents between the poles of novelty seeking and strong withdrawal. The strong dopaminergic vulnerability in this developmental phase further explains the dangers of alcohol and drug abuse or excessive media consumption. These can cause permanent disorders of the dopamine system, which increases the risk of impulsivity, addiction or psychosis.22
      Prolonged cortical maturation in the frontoparietal network has a favorable effect on the final performance of the brain, while acceleration, e.g. through too much dopaminergic stimulation, has an unfavorable effect.23 In both ADHD and giftedness, the maturation of the brain is slowed down.
      See Giftedness and ADHD In the section Differential diagnosis of ADHD in the chapter Diagnostics
  • Anxiety symptoms at the age of 15 make mental disorders in early adulthood much more likely24
    • Anxiety disorder: 4.9-fold
    • Depression: 4.8-fold
    • ADHD, ASD or developmental disorder: 3.4-fold
      This could be a further indication that middle adolescence represents a second particularly vulnerable developmental window alongside early childhood.
  • One theory assumes a post-maturation of brain functions. However, not every delay in brain maturation is also a sign of ADHD. In the case of giftedness, there is a delay in the development of the cortex that corresponds exactly to the delay until the first cortex thickness maximum occurs in ADHD.
    ADHD and giftedness.
  • Another theory is that certain regions of the brain take on compensatory tasks so that the child’s ADHD deficits can be corrected as a result.25
  • Another model assumes that certain childhood ADHD deficits persist throughout life.25
  • A study of adults with persistent ADHD found an imbalance between the connections in the brain within the default mode network on the one hand and those between the default mode network and the areas that support attention and cognitive control on the other. In adults whose ADHD was remitted, these differences did not exist.2627
  • A comparison of partially remitted and non-remitted adolescents found a significantly lower activation of the vlPFC in partial remission. This improvement in vlPFC efficiency correlated with performance on a go/no-go task and was intermediate between ADHD diagnosis and normal controls.28
  • A gene analysis study found four genome-wide significant loci for childhood ADHD and one for late onset ADHD. Elevated polygenic risk scores for ADHD (ADHD-PRS) were found in persistent ADHD. Childhood ADHD showed greater genetic overlap with hyperactivity and autism as well as the highest burden of rare protein truncating variants in evolutionarily restricted genes. Late onset ADHD, on the other hand, showed greater genetic overlap with depression and no increased burden of rare protein-truncating variants.13

3. Late onset ADHD: first occurrence in adulthood

The term late onset describes the first occurrence of ADHD in adulthood (from mid-20s). This is to be distinguished from a diagnosis made for the first time at this age.

3.1. Late diagnosis

Various long-term studies show that ADHD can also be diagnosed for the first time in adulthood. Depending on the study, this occurs in 0.4% to 10% of ADHD cases. For example, a study of young adults with ADHD found that only 12.6% had already been diagnosed with ADHD in childhood29

3.2. Late first occurrence (late onset)

One study examined 239 participants in the MTA study who had not been diagnosed with ADHD as children and 97 of whom showed ADHD symptoms as young adults:30
32 also showed the subjective stress required for a diagnosis.
Of these 32, 12 had been diagnosed with ADHD by one of the diagnostic sources at the time, but not by all sources, so no diagnosis was made.
Of the remaining 21, the current symptoms of 3 resulted from substance abuse.
Of the remaining 18, 9 already had other diagnoses of other disorders. In 5 cases, the symptoms were primarily attributed to the other disorder.
Of the 13 cases whose elevated ADHD symptoms and impairments first appeared in adolescence, 7 were excluded whose symptoms were reported only by a teacher or a teacher and themselves.
This means that the study found 6 cases (2.5% of the comparison group without ADHD at the start of the study) with late onset ADHD in adolescence.
In our opinion, the study is not suitable for assessing the frequency of late onset, as it overweights the exclusion criteria. On the one hand, those were excluded in whom only one source reported ADHD symptoms as a child and, at the same time, those were excluded in whom only one source reported symptoms in adolescence. Due to this double exclusion, the result should not be used to assess the frequency of late onset.
The study does, however, reliably establish that even from the most critical point of view, there is a group of people with ADHD with a late onset in late adolescence.

Another study examined the Pelotas birth cohort of n = 5,249 individuals born in Pelotas, Brazil, in 1993 through age 18 to 19 years, with 81.3% of participants remaining in the study.31
At the age of 11, 393 (8.9%) were found to have ADHD. Most of the people with ADHD were male (63.9%).
At 18 to 19 years of age, 492 (12.2%) met all DSM-5 criteria (excluding age at onset). After excluding comorbidities, a prevalence of 6.3% remained (256). Whether women predominated here (according to the wording) or were in the same minority (according to the figure of 39%) is unclear to us.
Both groups had higher levels of traffic accidents, criminal behavior, incarceration, suicide attempts and comorbidities in adulthood.
In the group of 18 to
However, only 60 children (17.2%) with ADHD still had ADHD at 18 to 19, and only 60 young adults (12.6%) with ADHD had ADHD at 11.
The results indicate a discontinuity of ADHD and a possible late onset. As many as 77.4% of the people with ADHD aged 18 to 19 would not have received an ADHD diagnosis according to the strict rules of DSM 5 (ADHD must have appeared at the age of 11 or earlier). This would deny people with ADHD meaningful and effective treatment, which is not justifiable from the point of view of the medical and psychotherapeutic duty of care. Barkley therefore rightly takes the view that the symptoms must have first appeared by the time the brain is fully developed (approx. 23 years).
The authors interpret the results as an indication of the existence of two syndromes with different developmental trajectories.
In view of the fact that ADHD is a syndrome that can arise from hundreds or even thousands of different causes, we believe that the different developmental trajectories could possibly also represent different sources of environmental influence. It is conceivable that certain environmental toxins or diseases contributed at different times. To determine this, a study of several birth cohorts from different countries could be helpful

3.3. Late-Onset ADHD: late-onset or late-diagnosed ADHD?

Nevertheless, we are of the opinion that a first occurrence in adulthood (late onset) should be rather rare. We assume that ADHD that occurs for the first time in adulthood usually already existed beforehand and was either overlooked, misdiagnosed or covered up by intensive coping until then. This kind of coping takes a lot of energy and very few people can manage it in the long term. Once the strength has been exhausted, the coping facade collapses and the ADHD becomes visible. This particularly affects women. In adults, the gender ratio of ADHD diagnoses is (almost) balanced.32
Women with a late diagnosis in particular suffer from the most severe symptoms and often comorbidities such as anxiety disorders or depression, which are a typical consequence of long untreated ADHD.
On the other hand, women are more susceptible to developing emotional disorders that start later (on average in adolescence), such as depression, dysthymia, various anxiety disorders or eating disorders. Sex hormones are often discussed as possible causes.33
A high oestrogen level alleviates deficits in learning and memory.34 This could possibly explain why ADHD symptoms are often not detectable in girls during their school years and only become more apparent in women from the age of 35.

Until DSM IV, the criteria for the diagnosis of ADHD stipulated that the first symptoms must have appeared by the age of 7. With DSM 5, this was increased to an age of 12 years.

Recent findings from population-based longitudinal studies suggest that in a subset of people with ADHD, ADHD symptoms only increase after childhood and they first meet the criteria for ADHD in later adolescence or early adulthood.353637383910294041 One study found 45% of people with ADHD who were first diagnosed as adults did not have ADHD in childhood. They showed lower hyperactivity/impulsivity symptoms and higher education. We see both as indications of a higher probability of an overlooked diagnosis in childhood with good coping skills. In addition, higher resilience is conceivable due to various protective factors.42

The updated European consensus on the treatment and diagnosis of ADHD in adults from 201843 points out that many people with ADHD have a poor memory and therefore have difficulty remembering events and details of their childhood and that there are reports of adults documenting the first onset of symptoms after the age of 12.4445

If the age by which the first symptoms must have appeared is set at 16, 99% of people with ADHD are covered, according to one study.46
This means that every hundredth case of ADHD still has its first symptoms after the age of 16. Assuming a prevalence of 8% for ADHD, this would mean 64,000 people in Germany, and at 5%, 40,000 people would have late-onset ADHD after the age of 16.
It is usually found that at least one symptom was highly pronounced in adolescence, which could indicate incorrect diagnosis in adolescence.47

Another study found in a survey of young adults with ADHD that only 12.6% already had ADHD in childhood.48 This means that ADHD could “appear” for the first time after the age of 6 or 12 (late onset) much more frequently than previously assumed. There is now clear evidence from extensive cohort studies in various countries that ADHD can also “appear” for the first time in adulthood.49 One study showed that in children with ADHD, the symptoms disappeared in up to 95% of people with ADHD in adulthood, while a significant proportion of adults with ADHD did not “have” ADHD as children.50 Several long-term studies over 20 to 40 years show that ADHD in children and ADHD in adults often affect separate groups of people. Moreover, in adults, gender participation was balanced, while in children there was still a male predominance. This could also indicate a separation of the groups of people.5152535432
We do believe that ADHD usually existed earlier and was just not diagnosed - whether due to ignorance on the part of doctors or therapists, due to intensive coping (e.g. in the case of high giftedness) or due to a good structure in the parental home, which is no longer present in independent adult life. Nevertheless, some questions remain unanswered.55
Regardless of this, it is of no use to adult persons with ADHD if they are denied treatment in adulthood due to a lack of childhood diagnosis. There are no reports that the usual treatment methods (especially stimulants) are less effective or less effective in late onset ADHD. In this respect, special observation by the attending physician may make sense, but refusing treatment would be a breach of the physician’s duty of care. We see this in particular when a doctor refuses a diagnosis in adulthood solely on the basis of a lack of primary school reports, although the symptoms show a full ADHD picture. The notoriously poor long-term memory of persons with ADHD and the ADHD-symptomatic increased disorganization, in which a retrievable storage of primary school reports by the person with ADHD himself would almost be an argument against ADHD, cannot justify a refusal of a diagnosis in such a case for this reason alone.

One publication reports that the severity of ADHD should be milder if it occurs later.38 This is in contrast to reports that late-diagnosed women in particular tend to have more severe symptoms with strong comorbidity (depression, anxiety).54
The risk of being (diagnosed with) ADHD for the first time in adulthood also appears to be related to comorbidities. (ADHD)-typical comorbidities existing in childhood seem to increase the risk of developing ADHD in old age - just as (which has been known for some time) ADHD in childhood increases the risk of developing typical comorbidities in adulthood.5657

A long-term study found that of 318 children with birth problems, at age 40 those who had developed ADHD as a child were only 21% ADHD, but had poorer educational attainment, more ADHD symptoms and executive problems. Those who had attention problems as a child but not full-blown ADHD had 6.6% ADHD at age 40; those who did not show attention problems as a child had 6% ADHD. Controls without birth problems had 1.6% ADHD at 40.58 Accordingly, around 6 to 6.6 % of those children with birth problems and 1.6 % of those without birth problems could be diagnosed with ADHD for the first time at the age of 40.

A study of 488 consecutive patients admitted to a special outpatient clinic for dementia found ADHD in 7 patients who were initially suspected of having an early form of Alzheimer’s dementia. These 7 persons with ADHD of “very late onset ADHD” or “senile onset ADHD” had four characteristics in common:59

  • significantly younger (< 65 years) than the overall study population
  • predominantly inattention-related symptoms
  • latent manifestation
  • stressful life event before the manifestation (stress experience)

4. ADHD symptoms change in adults

The DSM IV criteria for ADHD describe the symptoms of children and not specifically those of adults.60
The symptoms of ADHD in adults change considerably compared to those of ADHD in children.6162 Hyperactivity in particular is significantly reduced. Symptoms such as inner restlessness, inability to relax and “constantly having to be active” come to the fore.

One study reports a linear decline in hyperactivity from 6 to 2.9 points between the ages of 8 and 16.63 Inattention only fell from 5.8 to 4.9 points in the same period.
However, another study shows that hyperactivity - measured here using infrared movement sensors during the performance of attention tests - is a better discriminator than attention problems, even in adults. Even in people with ADHD-I, a predominantly inattentive subtype, hyperactivity / restlessness of movement was found to be significantly higher than in non-affected people.64

Adults have a far greater opportunity to organize their lives in such a way that the peculiarities of ADHD (short attention span, high distractibility, preference for fast task switching) are no longer a burden but an advantage. Children have to submit to strict external control - especially at school. The trait of people with ADHD (and especially people with ADHD-HI) of increased intrinsic and reduced extrinsic motivation is a hindrance in a purely extrinsically motivating school environment.65

For the sake of completeness, it should be noted with regard to Friedman that the frustration of people with ADHD of doing something they are not really interested in and which, by its very nature, they are not particularly good at (which applies to all people, but is particularly true for people with ADHD) causes considerable stress. It is well known that people with ADHD react more intensely to stress. All ADHD symptoms are classic stress symptoms. People with ADHD have an overreactive stress response system.
ADHD as a chronic stress regulation disorder

Barkley has drawn up a list of typical symptoms of ADHD in adults and verified it through research. Physical hyperactivity decreases significantly, inner restlessness becomes more visible. Inattention also decreases significantly.

The following symptoms predominate in adults:

  • Inattention (reduced by up to 40% compared to children)
    Attention problems decrease by up to 40% in adults compared to children and adolescents (the decrease is thus less than that of the other main symptoms).66 These figures are taken from the data in Biedermann’s publication. We cannot understand why the specialist literature interprets them differently. However, the decline in attention problems in adults that can be read from the data is consistent with our perception (at least for some people with ADHD). One study reports a linear decline in inattention from 5.8 to 4.9 points between the ages of 8 and 16.63
    Other sources, however, report an increase in inattention at the age of67 and consistent attention problems and executive problems from working memory between the ages of 60 and 94, some of which stemmed from depression.68
  • Hyperactivity (reduced by up to 60 % compared to children)
    Hyperactivity transforms into inner restlessness in adulthood (Barkley) and decreases by up to 60% compared to children/adolescents6663 We suspect that this is not so much a transformation as that the symptoms of inner tension become more clearly visible after the hyperactivity has subsided.
  • Impulsiveness (reduced by up to 60 % compared to children)
    According to various sources, impulsivity is said to decrease by up to 60% compared to children / adolescents666963
    Another study found no change in impulsivity with age.67
  • Emotional overreactivity (increased in adults)70
  • Affect lability71
  • Disorganization71

One study found four patterns of hyperactivity and inattention between childhood and adulthood:72

  • Hyperactivity
    • was low, stay low
    • was high, decreased
  • Inattention
    • was low, remained low
    • was high, continued to rise

Some changes can also be measured neurophysiologically.

While there is a reduction in striatal and prefrontal dopa decarboxylase activity in children with hyperactivity,73 this is not reproducible in adults with ADHD-HI.74 Furthermore, no increase in HVA was detectable in the CSF of adults with ADHD. This also indicates that persistent ADHD in adulthood has an altered pathophysiological basis.75 However, the HVA value is merely a global value for dopamine metabolism, whereas in ADHD the dopamine level of different brain regions must be differentiated.

Adults apparently have a significantly lower number of dopamine transporters in the striatum than children. For every 10 years of age, there is a decrease of 7 %, with the decrease being significantly higher up to around 40 years of age than thereafter. In 50-year-olds, the number of DATs is only about half as high as in 10-year-olds.7677
At the same time, the number of dopaminergic neurons decreases with age. The amount of phasically released and basal extracellular dopamine in the striatum remains the same.78

The problems and quality of life impairments of older adults with ADHD are similar to those of younger adults with ADHD, according to a study. This suggests that there is no long-term improvement with further ageing during adulthood.79

Reif, on the other hand, assumes that inattention decreases only slightly, while emotional dysregulation becomes stronger in adulthood.80
We believe that emotional dysregulation is a more accepted trait in children (“immaturity”), whereas it is perceived as inappropriate in adults. We therefore wonder whether emotional dysregulation is actually increasing in adults with ADHD or whether emotional imbalance is already present in children with ADHD, but is still perceived as acceptable and therefore not as an ADHD symptom - as we suspect is the case with internal tension, which is perceived in adulthood after physical hyperactivity decreases. We want to research this in more detail.

5. Treatment for adults

In adults, significantly lower amounts of stimulants are usually required to correct the dopamine and noradrenaline deficit in the reinforcement system and in the dlPFC, which could be related to the fact that the excess of dopamine transporters compared to children apparently partially regresses.
A (starting) dosage of stimulants as for children would therefore be medical malpractice. Irrespective of this, stimulant treatment should always be started with dosages of 2.5 mg / below the smallest packaging dosage sizes for sensible dosing with stimulants.

6. Remission in adulthood

One study examined adults three times at 7-year intervals, from an average age of 34 to an average age of 47, and showed a remission rate of 5.7%.81
One individual case reported a complete remission of his clear adult ADHD-C as a result of a corona infection. After three quarters of a year, the ADHD symptoms slowly returned. It is quite conceivable that diseases alter the dopamine system. Just as certain viral diseases can be a risk for ADHD because they can trigger a dopamine and noradrenaline deficiency, this is also possible in the opposite direction.

7. ADHD in old age

There are few studies on the symptoms, diagnosis and treatment of ADHD in older adults.82


  1. Edel, Vollmoeller (2006): Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Springer Seite 51

  2. Schlack, Holling, Kurth, Huss (2007): Die Prävalenz der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Kindern und Jugendlichen in Deutschland. Erste Ergebnisse aus dem Kinder- und Jugendgesundheitssurvey (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50:827-835.

  3. Kessler, Adler, Barkley, Biederman, Conners, Demler, Faraone, Greenhill, Howes, Secnik, Spencer, Ustun, Walters, Zaslavsky (2006): The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication; THE AMERICAN JOURNAL OF PSYCHIATRY April 2006 Volume 163, Issue 4, April, 2006, pp. 716-723

  4. Krause, Krause (2014): ADHS im Erwachsenenalter, Schattauer, Kapitel Prävalenz, S. 9 ff

  5. Faraone, Biederman, Mick (2006): The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006 Feb;36(2):159-65.

  6. Sibley, Arnold, Swanson, Hechtman, Kennedy, Owens, Molina, Jensen, Hinshaw, Roy, Chronis-Tuscano, Newcorn, Rohde (2021): MTA Cooperative Group. Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. Am J Psychiatry. 2021 Aug 13:appiajp202121010032. doi: 10.1176/appi.ajp.2021.21010032. PMID: 34384227. n = 558

  7. Barkley, Vortrag (2007): Adult Outcomes of Children with ADHD: The Milwaukee Study. Folien 12/20 und 19/20.

  8. Sibley, Arnold, Swanson, Hechtman, Kennedy, Owens, Molina, Jensen, Hinshaw, Roy, Chronis-Tuscano, Newcorn, Rohde; MTA Cooperative Group (2022): Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. Am J Psychiatry. 2022 Feb;179(2):142-151. doi: 10.1176/appi.ajp.2021.21010032. PMID: 34384227; PMCID: PMC8810708.

  9. Biederman, Petty, Evans, Small, Faraone (2010): How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res. 2010 May 30;177(3):299-304. doi: 10.1016/j.psychres.2009.12.010. PMID: 20452063; PMCID: PMC2881837.

  10. Agnew-Blais, Polanczyk, Danese, Wertz, Moffitt, Arseneault (2016): Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood. JAMA Psychiatry. 2016 Jul 1;73(7):713-20. doi: 10.1001/jamapsychiatry.2016.0465.

  11. Van Meter AR, Sibley MH, Vandana P, Birmaher B, Fristad MA, Horwitz S, Youngstrom EA, Findling RL, Arnold LE. The stability and persistence of symptoms in childhood-onset ADHD. Eur Child Adolesc Psychiatry. 2023 Jun 4. doi: 10.1007/s00787-023-02235-3. PMID: 37270740.

  12. Kooij, Bijlenga, Salerno, Jaeschke, Bitter, Balázs, Thome, Dom, Kasper, Filipe, Stes, Mohr, Leppämäki, Brugué, Bobes, Mccarthy, Richarte, Philipsen, Pehlivanidis, Niemela, Styr, Semerci, Bolea-Alamanac, Edvinsson, Baeyens, Wynchank, Sobanski, Philipsen, McNicholas, Caci, Mihailescu, Manor, Dobrescu, Krause, Fayyad, Ramos-Quiroga, Foeken, Rad, Adamou, Ohlmeier, Fitzgerald, Gill, Lensing, Mukaddes, Brudkiewicz, Gustafsson, Tania, Oswald, Carpentier, De Rossi, Delorme, Simoska, Pallanti, Young, Bejerot, Lehtonen, Kustow, Müller-Sedgwick, Hirvikoski, Pironti, Ginsberg, Félegeházy, Garcia-Portilla, Asherson (2018): Updated European Consensus Statement on diagnosis and treatment of adult ADHD, European Psychiatrie, European Psychiatry 56 (2019) 14–34, http://dx.doi.org/10.1016/j.eurpsy.2018.11.001

  13. Rajagopal, Duan, Vilar-Ribó, Grove, Zayats, Ramos-Quiroga, Satterstrom, Artigas, Bybjerg-Grauholm, Bækvad-Hansen, Als, Rosengren, Daly, Neale, Nordentoft, Werge, Mors, Hougaard, Mortensen, Ribasés, Børglum, Demontis (2022): Differences in the genetic architecture of common and rare variants in childhood, persistent and late-diagnosed attention-deficit hyperactivity disorder. Nat Genet. 2022 Aug;54(8):1117-1124. doi: 10.1038/s41588-022-01143-7. PMID: 35927488. n = 77.914

  14. Roselló, Berenguer, Baixauli, Mira, Martinez-Raga, Miranda (2020): Empirical examination of executive functioning, ADHD associated behaviors, and functional impairments in adults with persistent ADHD, remittent ADHD, and without ADHD. BMC Psychiatry. 2020 Mar 24;20(1):134. doi: 10.1186/s12888-020-02542-y. PMID: 32204708; PMCID: PMC7092442. n = 105

  15. Fayyad, Sampson, Hwang, Adamowski, Aguilar-Gaxiola, Al-Hamzawi, Andrade, Borges, de Girolamo, Florescu, Gureje, Haro, Hu, Karam, Lee, Navarro-Mateu, O’Neill, Pennell, Piazza, Posada-Villa, Ten Have, Torres, Xavier, Zaslavsky, Kessler; WHO World Mental Health Survey Collaborators (2017): The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65. doi: 10.1007/s12402-016-0208-3.

  16. Tistarelli, Fagnani, Troianiello, Stazi, Adriani (2019): The nature and nurture of ADHD and its comorbidities: a narrative review on twin studies. Neurosci Biobehav Rev. 2019 Dec 12. pii: S0149-7634(19)30552-4. doi: 10.1016/j.neubiorev.2019.12.017.

  17. Barkley, Murphy, Fischer (2008). ADHD in Adults: What the Science Says. New York: Guilford, Seite 436

  18. Kim, King, Jennings (2019): ADHD remission, inclusive special education, and socioeconomic disparities. SSM Popul Health. 2019 May 30;8:100420. doi: 10.1016/j.ssmph.2019.100420. eCollection 2019 Aug.

  19. Hartman, Rommelse, van der Klugt, Wanders, Timmerman (2019): Stress Exposure and the Course of ADHD from Childhood to Young Adulthood: Comorbid Severe Emotion Dysregulation or Mood and Anxiety Problems. J Clin Med. 2019 Nov 1;8(11). pii: E1824. doi: 10.3390/jcm8111824. n = 609

  20. Björkenstam, Björkenstam, Jablonska, Kosidou (2018): Cumulative exposure to childhood adversity, and treated attention deficit/hyperactivity disorder: a cohort study of 543 650 adolescents and young adults in Sweden. Psychol Med. 2018 Feb;48(3):498-507. doi: 10.1017/S0033291717001933.

  21. Sibley, Ortiz, Graziano, Dick, Estrada (2019): Metacognitive and motivation deficits, exposure to trauma, and high parental demands characterize adolescents with late-onset ADHD. Eur Child Adolesc Psychiatry. 2019 Aug 6. doi: 10.1007/s00787-019-01382-w.

  22. Braus (2004) EinBlick ins Gehirn ä eine andere Einführung in die Psychiatrie. S. 19

  23. Braus (2004) EinBlick ins Gehirn – eine andere Einführung in die Psychiatrie. S. 19

  24. Doering, Lichtenstein, Gillberg, Middeldorp, Bartels, Kuja-Halkola, Lundström (2019): Anxiety at age 15 predicts psychiatric diagnoses and suicidal ideation in late adolescence and young adulthood: results from two longitudinal studies. BMC Psychiatry. 2019 Nov 14;19(1):363. doi: 10.1186/s12888-019-2349-3. n = 14.106 + 9.211

  25. Sudre, Mangalmurti, Shaw (2018): Growing out of attention deficit hyperactivity disorder: insights from the ‘remitted’ brain. Neurosci Biobehav Rev. 2018 Sep 5. pii: S0149-7634(18)30313-0. doi: 10.1016/j.neubiorev.2018.08.010.

  26. Sudre, Szekely, Sharp, Kasparek, Shaw (2017): Multimodal mapping of the brain’s functional connectivity and the adult outcome of attention deficit hyperactivity disorder; PNAS October 31, 2017 114 (44) 11787-11792; https://doi.org/10.1073/pnas.1705229114

  27. Kooij, Bijlenga, Salerno, Jaeschke, Bitter, Balázs, Thome, Dom, Kasper, Filipe, Stes, Mohr, Leppämäki, Brugué, Bobes, Mccarthy, Richarte, Philipsen, Pehlivanidis, Niemela, Styr, Semerci, Bolea-Alamanac, Edvinsson, Baeyens, Wynchank, Sobanski, Philipsen, McNicholas, Caci, Mihailescu, Manor, Dobrescu, Krause, Fayyad, Ramos-Quiroga, Foeken, Rad, Adamou, Ohlmeier, Fitzgerald, Gill, Lensing, Mukaddes, Brudkiewicz, Gustafsson, Tania, Oswald, Carpentier, De Rossi, Delorme, Simoska, Pallanti, Young, Bejerot, Lehtonen, Kustow, Müller-Sedgwick, Hirvikoski, Pironti, Ginsberg, Félegeházy, Garcia-Portilla, Asherson (2018): Updated European Consensus Statement on diagnosis and treatment of adult ADHD, European Psychiatrie, European Psychiatry 56 (2019) 14–34, http://dx.doi.org/10.1016/j.eurpsy.2018.11.001

  28. Schulz, Newcorn, Fan, Tang, Halperin (2005): Brain activation gradients in ventrolateral prefrontal cortex related to persistence of ADHD in adolescent boys. J Am Acad Child Adolesc Psychiatry. 2005 Jan;44(1):47-54. doi: 10.1097/01.chi.0000145551.26813.f9. PMID: 15608543.

  29. Caye, Rocha, Anselmi, Murray, Menezes, Barros, Gonçalves, Wehrmeister, Jensen, Steinhausen, Swanson, Kieling, Rohde (2016): Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome. JAMA Psychiatry. 2016 Jul 1;73(7):705-12. doi: 10.1001/jamapsychiatry.2016.0383.

  30. Sibley MH, Rohde LA, Swanson JM, Hechtman LT, Molina BSG, Mitchell JT, Arnold LE, Caye A, Kennedy TM, Roy A, Stehli A; Multimodal Treatment Study of Children with ADHD (MTA) Cooperative Group (2018): Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25. Am J Psychiatry. 2018 Feb 1;175(2):140-149. doi: 10.1176/appi.ajp.2017.17030298. PMID: 29050505; PMCID: PMC5814300.

  31. Caye A, Rocha TB, Anselmi L, Murray J, Menezes AM, Barros FC, Gonçalves H, Wehrmeister F, Jensen CM, Steinhausen HC, Swanson JM, Kieling C, Rohde LA (2016): Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome. JAMA Psychiatry. 2016 Jul 1;73(7):705-12. doi: 10.1001/jamapsychiatry.2016.0383. PMID: 27192050.

  32. London, Landes (2019): Cohort Change in the Prevalence of ADHD Among U.S. Adults: Evidence of a Gender-Specific Historical Period Effect. J Atten Disord. 2019 Jun 13:1087054719855689. doi: 10.1177/1087054719855689.

  33. Martel MM, Klump K, Nigg JT, Breedlove SM, Sisk CL (2009): Potential hormonal mechanisms of attention-deficit/hyperactivity disorder and major depressive disorder: a new perspective. Horm Behav. 2009 Apr;55(4):465-79. doi: 10.1016/j.yhbeh.2009.02.004. PMID: 19265696; PMCID: PMC3616481.

  34. Iqbal J, Huang GD, Xue YX, Yang M, Jia XJ (2024): Role of estrogen in sex differences in memory, emotion and neuropsychiatric disorders. Mol Biol Rep. 2024 Mar 12;51(1):415. doi: 10.1007/s11033-024-09374-z. PMID: 38472517. REVIEW

  35. Liu, Asherson, Viding, Greven, Pingault (2019): Early Predictors of De Novo and Subthreshold Late-Onset ADHD in a Child and Adolescent Cohort. J Atten Disord. 2019 Dec 30:1087054719892888. doi: 10.1177/1087054719892888.

  36. Cooper, Hammerton, Collishaw, Langley, Thapar, Dalsgaard, Stergiakouli, Tilling, Davey Smith, Maughan, O’Donovan, Thapar, Riglin (2018): Investigating late-onset ADHD: a population cohort investigation. J Child Psychol Psychiatry. 2018 Oct;59(10):1105-1113. doi: 10.1111/jcpp.12911.

  37. Liu, Li, Viding, Asherson, Pingault (2018): The developmental course of inattention symptoms predicts academic achievement due to shared genetic aetiology: a longitudinal twin study. Eur Child Adolesc Psychiatry. 2019 Mar;28(3):367-375. doi: 10.1007/s00787-018-1200-6.

  38. Murray, Booth, Auyeung, Eisner, Ribeaud, Obsuth (2018): Outcomes of ADHD Symptoms in Late Adolescence: Are Developmental Subtypes Important? J Atten Disord. 2018 Aug 22:1087054718790588. doi: 10.1177/1087054718790588.

  39. Murray, Eisner, Obsuth, Ribeaud (2017): Identifying Early Markers of “Late Onset” Attention Deficit and Hyperactivity/Impulsivity Symptoms. J Atten Disord. 2017 Apr 1:1087054717705202. doi: 10.1177/1087054717705202.

  40. Pingault, Viding, Galéra, Greven, Zheng, Plomin, Rijsdijk (2015): Genetic and Environmental Influences on the Developmental Course of Attention-Deficit/Hyperactivity Disorder Symptoms From Childhood to Adolescence. JAMA Psychiatry. 2015 Jul;72(7):651-8. doi: 10.1001/jamapsychiatry.2015.0469. n = 8.395 Zwillingspaare

  41. Pingault, Tremblay, Vitaro, Carbonneau, Genolini, Falissard, Côté (2011): Childhood trajectories of inattention and hyperactivity and prediction of educational attainment in early adulthood: a 16-year longitudinal population-based study. Am J Psychiatry. 2011 Nov;168(11):1164-70. doi: 10.1176/appi.ajp.2011.10121732. n = 2000

  42. Jurek L, Montègue S, Larrieu A, Icard C, Rolland B (2023): Compared Profile of Late-Onset Versus Childhood-Onset ADHD: A Case-Control Study Among Treatment-Seeking Adult Patients. J Atten Disord. 2023 Aug 11:10870547231191756. doi: 10.1177/10870547231191756. PMID: 37565344.

  43. Kooij, Bijlenga, Salerno, Jaeschke, Bitter, Balázs, Thome, Dom, Kasper, Filipe, Stes, Mohr, Leppämäki, Brugué, Bobes, Mccarthy, Richarte, Philipsen, Pehlivanidis, Niemela, Styr, Semerci, Bolea-Alamanac, Edvinsson, Baeyens, Wynchank, Sobanski, Philipsen, McNicholas, Caci, Mihailescu, Manor, Dobrescu, Krause, Fayyad, Ramos-Quiroga, Foeken, Rad, Adamou, Ohlmeier, Fitzgerald, Gill, Lensing, Mukaddes, Brudkiewicz, Gustafsson, Tania, Oswald, Carpentier, De Rossi, Delorme, Simoska, Pallanti, Young, Bejerot, Lehtonen, Kustow, Müller-Sedgwick, Hirvikoski, Pironti, Ginsberg, Félegeházy, Garcia-Portilla, Asherson (2018): Updated European Consensus Statement on diagnosis and treatment of adult ADHD, European Psychiatrie, European Psychiatry 56 (2019) 14–34, http://dx.doi.org/10.1016/j.eurpsy.2018.11.001, Seite 17

  44. Faraone, Kunwar, Adamson, Biederman (2009): Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses; Psychol Med. 2009 Apr; 39(4): 685–693. doi: [10.1017/S0033291708003917]; PMCID: PMC2874959; NIHMSID: NIHMS199982; PMID: 18588742

  45. Chandra, Biederman, Faraone (2016): Assessing the Validity of the Age at Onset Criterion for Diagnosing ADHD in DSM-5; J Atten Disord. 2016 Feb 27. pii: 1087054716629717.

  46. Kieling, Kieling, Rohde, Frick, Moffitt, Nigg, Tannock, Castellanos (2010): Am J Psychiatry. 2010 Jan;167(1):14-6. doi: 10.1176/appi.ajp.2009.09060796.

  47. Kooij, Bijlenga, Salerno, Jaeschke, Bitter, Balázs, Thome, Dom, Kasper, Filipe, Stes, Mohr, Leppämäki, Brugué, Bobes, Mccarthy, Richarte, Philipsen, Pehlivanidis, Niemela, Styr, Semerci, Bolea-Alamanac, Edvinsson, Baeyens, Wynchank, Sobanski, Philipsen, McNicholas, Caci, Mihailescu, Manor, Dobrescu, Krause, Fayyad, Ramos-Quiroga, Foeken, Rad, Adamou, Ohlmeier, Fitzgerald, Gill, Lensing, Mukaddes, Brudkiewicz, Gustafsson, Tania, Oswald, Carpentier, De Rossi, Delorme, Simoska, Pallanti, Young, Bejerot, Lehtonen, Kustow, Müller-Sedgwick, Hirvikoski, Pironti, Ginsberg, Félegeházy, Garcia-Portilla, Asherson (2018): Updated European Consensus Statement on diagnosis and treatment of adult ADHD, European Psychiatrie, European Psychiatry 56 (2019) 14–34, http://dx.doi.org/10.1016/j.eurpsy.2018.11.001, Seite 20

  48. Caye, Rocha, Anselmi, Murray, Menezes, Barros, Gonçalves, Wehrmeister, Jensen, Steinhausen, Swanson, Kieling, Rohde (2016): Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome. JAMA Psychiatry. 2016 Jul 1;73(7):705-12. doi: 10.1001/jamapsychiatry.2016.0383. n = 5249

  49. Asherson, Agnew-Blais (2019): Annual Research Review: Does late-onset attention-deficit/hyperactivity disorder exist? J Child Psychol Psychiatry. 2019 Mar 7. doi: 10.1111/jcpp.13020.

  50. Müller (2018): Kinder tragen ADHS nur selten ins Erwachsenenalter. Ärztezeitung online 07.06.2018

  51. Moffitt, Houts, Asherson, Belsky, Corcoran, Hammerle, Harrington, Hogan, Meier, Polanczyk, Poulton, Ramrakha, Sugden, Williams, Rohde, Caspi (2015): Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study; American Journal of Psychiatry 2015 172:10, 967-977

  52. Shaw, Polanczyk (2017): Combining epidemiological and neurobiological perspectives to characterize the lifetime trajectories of ADHD. Eur Child Adolesc Psychiatry (2017) 26: 139. https://doi.org/10.1007/s00787-017-0944-8

  53. Caye, Rocha, Anselmi, Murray, Menezes, Barros, Gonçalves, Wehrmeister, Jensen, Steinhausen, Swanson, Kieling, Rohde (2016): Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome. JAMA Psychiatry. 2016 Jul 1;73(7):705-12. doi: 10.1001/jamapsychiatry.2016.0383.

  54. Riglin, Eyre, Thapar, Stringaris, Leibenluft, Pine, Tilling, Smith, O’Donovan, Thapar (2019): Identifying Novel Types of Irritability Using a Developmental Genetic Approach. Am J Psychiatry. 2019 Aug 1;176(8):635-642. doi: 10.1176/appi.ajp.2019.18101134.

  55. Ilario C1, Alt A1, Bader M2, Sentissi (2019): Can ADHD have an adulthood onset? (Article in French). Encephale. 2019 Jun 26. pii: S0013-7006(19)30206-4. doi: 10.1016/j.encep.2019.05.004.

  56. Plana-Ripoll, Pedersen, Holtz, Benros, Dalsgaard, de Jonge, Fan, Degenhardt, Ganna, Greve, Gunn, Iburg, Kessing, Lee, Lim, Mors, Nordentoft, Prior, Roest, Saha, Schork, Scott, Scott, Stedman, Sørensen, Werge, Whiteford, Laursen, Agerbo, Kessler, Mortensen, McGrath (2019): Exploring Comorbidity Within Mental Disorders Among a Danish National Population. JAMA Psychiatry. 2019;76(3):259-270. doi:10.1001/jamapsychiatry.2018.3658 201976(3):259–270.

  57. Polanczyk, Casella, Jaffee (2019): Commentary: ADHD lifetime trajectories and the relevance of the developmental perspective to Psychiatry: reflections on Asherson and Agnew-Blais. J Child Psychol Psychiatry. 2019 Apr;60(4):353-355. doi: 10.1111/jcpp.13050.

  58. Schiavone, Virta, Leppämäki, Launes, Vanninen, Tuulio-Henriksson, Immonen, Järvinen, Lehto, Michelsson, Hokkanen (2019): ADHD and subthreshold symptoms in childhood and life outcomes at 40 years in a prospective birth-risk cohort. Psychiatry Res. 2019 Sep 25;281:112574. doi: 10.1016/j.psychres.2019.112574.

  59. Sasaki, Jono, Fukuhara, Honda, Ishikawa, Boku, Takebayashi (2022): Late-manifestation of attention-deficit/hyperactivity disorder in older adults: an observational study. BMC Psychiatry. 2022 May 24;22(1):354. doi: 10.1186/s12888-022-03978-0. PMID: 35610630; PMCID: PMC9128193.

  60. Barkley, der an der Kriterienerstellung des DSM IV mitgewirkt hat, in Barkley, Benton (2012, 2017): Das große Handbuch für Erwachsene mit ADHS

  61. Barkley, Benton (2012, 2017): Das große Handbuch für Erwachsene mit ADHS

  62. Edel, Vollmoeller (2006): Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Springer, Seite 46

  63. Pingault, Viding, Galéra, Greven, Zheng, Plomin, Rijsdijk (2015): Genetic and Environmental Influences on the Developmental Course of Attention-Deficit/Hyperactivity Disorder Symptoms From Childhood to Adolescence. JAMA Psychiatry. 2015 Jul;72(7):651-8. doi: 10.1001/jamapsychiatry.2015.0469.

  64. Teicher, Polcar, Fourligas, Vitaliano, Navalta (2012): Hyperactivity persists in male and female adults with ADHD and remains a highly discriminative feature of the disorder: a case-control study. BMC Psychiatry. 2012 Nov 7;12:190. doi: 10.1186/1471-244X-12-190. PMID: 23134619; PMCID: PMC3560176. n = 100

  65. so auch Friedmann, in New York Times Online: A Natural Fix on A.D.H.D, Sunday Review, 31.10.2014

  66. Edel, Vollmoeller (2006): Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Springer, Seite 51, mit Verweis auf Biederman, Mick, Faraone (2000): Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission defi nition and symptom type. Am J Psychiatry 157:816–818

  67. Bijlenga, Ulberstad, Thorell, Christiansen, Hirsch, Kooij (2019): Objective assessment of attention-deficit/hyperactivity disorder in older adults compared with controls using the QbTest. Int J Geriatr Psychiatry. 2019 Jun 26. doi: 10.1002/gps.5163.

  68. Semeijn, Korten, Comijs, Michielsen, Deeg, Beekman, Kooij (2015) No lower cognitive functioning in older adults with attention-deficit/hyperactivity disorder. Int Psychogeriatr. 2015 Sep;27(9):1467-76. doi: 10.1017/S1041610215000010.

  69. Areces, García, Cueli, Rodríguez (2019): Is a Virtual Reality Test Able to Predict Current and Retrospective ADHD Symptoms in Adulthood and Adolescence? Brain Sci. 2019 Oct 13;9(10). pii: E274. doi: 10.3390/brainsci9100274.

  70. Edel, Vollmoeller (2006): Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Springer, Seite 82, mit Verweis auf Biederman, Mick, Faraone (2000): Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission defi nition and symptom type. Am J Psychiatry 157:816–818

  71. Edel, Vollmoeller (2006): Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Springer, Seite 82, mwN

  72. Larsson H, Dilshad R, Lichtenstein P, Barker ED (2011): Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry. 2011 Sep;52(9):954-63. doi: 10.1111/j.1469-7610.2011.02379.x. PMID: 21434915.

  73. Ernst, Zametkin, Matochik, Jons, Cohen (1998): DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A (fluorine-18) fluorodopa positron emission tomographic study; J. Neurosci. 18, 5901-5907, 1998 zitiert nach Franck (2003): Hyperaktivität und Schizophrenie – eine explorative Studie; Dissertation, Seite 68

  74. Franck (2003): Hyperaktivität und Schizophrenie – eine explorative Studie; Dissertation, Seite 68

  75. Ernst, Liebenauer, Tebeka, Jons, Eisenhofer, Murphy, Zametkin (1997): Selegiline in ADHD adults: Plasma monoamine and monoamine metabolites. Neuropsychopharmacology 16, 276-284, 1997, zitiert nach Franck (2003): Hyperaktivität und Schizophrenie – eine explorative Studie; Dissertation, Seite 68

  76. Krause, Krause (2014): ADHS im Erwachsenenalter, Schattauer, Seite 232, mit etlichen Nachweisen

  77. Dougherty, Bonab, Spencer, Rauch, Madras, Fischman (1999): Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354: 2132-2133; Article (PDF Available) in The Lancet 354(9196):2132-3 · December 1999 with 294 Reads (Stand 10/2016); DOI: 10.1016/S0140-6736(99)04030-1 · Source: PubMe

  78. Speranza L, di Porzio U, Viggiano D, de Donato A, Volpicelli F (2021): Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control. Cells. 2021 Mar 26;10(4):735. doi: 10.3390/cells10040735. PMID: 33810328; PMCID: PMC8066851. REVIEW

  79. Thorell, Holst, Sjöwall (2019): Quality of life in older adults with ADHD: links to ADHD symptom levels and executive functioning deficits. Nord J Psychiatry. 2019 Aug 5:1-8. doi: 10.1080/08039488.2019.1646804.

  80. Vortrag Andreas Reif (2017): Fokus ADHS, Minute 29

  81. Grevet EH, Bandeira CE, Vitola ES, de Araujo Tavares ME, Breda V, Zeni G, Teche SP, Picon FA, Salgado CAI, Karam RG, da Silva BS, Sibley MH, Rohde LA, Cupertino RB, Rovaris DL, Bau CHD (2022): The course of attention-deficit/hyperactivity disorder through midlife. Eur Arch Psychiatry Clin Neurosci. 2022 Dec 9. doi: 10.1007/s00406-022-01531-4. PMID: 36484846.

  82. Dobrosavljevic M, Larsson H, Cortese S (2023): The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults. Expert Rev Neurother. 2023 Jul-Dec;23(10):883-893. doi: 10.1080/14737175.2023.2250913. PMID: 37725058. REVIEW